Fortis Healthcare Limited announced its un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company reported total income of ₹61,091 lacs for the standalone quarter and ₹274,154 lacs for the consolidated quarter. Net profit for the standalone quarter stood at ₹12,991 lacs, while the consolidated net profit was ₹32,047 lacs.
Fortis Healthcare Announces Q2 FY27 Financial Results
Fortis Healthcare Limited has disclosed its un-audited standalone and consolidated financial results for the second quarter and the first half of the financial year ending September 30, 2026. The announcements were made on November 5, 2026, following the Board of Directors’ meeting.
Standalone Financial Highlights
For the standalone operations for the quarter ended September 30, 2026, Fortis Healthcare reported total income of ₹61,091 lacs. The total expenses amounted to ₹47,206 lacs, leading to a net profit of ₹12,991 lacs for the period. The total comprehensive income for the quarter was ₹13,142 lacs. For the six months ended September 30, 2026, the standalone revenue from operations was ₹100,886 lacs, with a net profit of ₹17,769 lacs and a total comprehensive income of ₹17,920 lacs.
Consolidated Financial Highlights
On a consolidated basis, for the quarter ended September 30, 2026, the company’s total income reached ₹274,154 lacs. Total expenses were recorded at ₹231,827 lacs, resulting in a net profit of ₹32,047 lacs. The total comprehensive income for the quarter was ₹32,874 lacs. For the six months ended September 30, 2026, consolidated revenue from operations stood at ₹527,986 lacs, with a net profit of ₹59,327 lacs and a total comprehensive income of ₹60,164 lacs.
Auditor’s Report and Review
The financial results are accompanied by a Limited Review Report from the statutory auditors, BSR & Co. LLP. The report confirms that based on their review, nothing has come to their attention that causes them to believe that the accompanying statement contains any material misstatement. However, the report draws attention to notes concerning ongoing investigations by the Serious Fraud Investigation Office (SFIO) and other regulatory matters, which are being handled in cooperation with the authorities.
Segment Reporting
The consolidated results also include segment reporting, detailing performance for Healthcare and Diagnostics. For the quarter ended September 30, 2026, the Healthcare segment generated revenue of ₹234,024 lacs with a profit before tax of ₹43,231 lacs. The Diagnostics segment reported revenue of ₹44,822 lacs and profit before tax of ₹43,231 lacs.
Source: BSE
